Jubilant Ingrevia Q2 FY27: Nutrition EBITDA up 87% YoY, Chemical Intermediates revenue up 24%; ZettaOne to build Bengaluru plant
Jubilant Ingrevia says ZettaOne Technologies is establishing a new manufacturing facility near Bengaluru.
By ScoutQuest · · 1 min read
- Nutrition & Health Solutions EBITDA
- rose 87% YoY to ₹39 crore
- Chemical Intermediates revenue
- rose 24% YoY to ₹563 crore
- Basic and diluted EPS, Q2 FY27
- up 61% YoY
- Release
- Results press release
- Period
- Q2 FY27
_Basis not stated · Q2 FY27_
📊 Basic and diluted EPS, Q2 FY27: up 61% YoY
🏭 Jubilant Ingrevia says the shareholders' agreement for its ZettaOne Technologies Limited stake will be concluded soon. ZettaOne is establishing a new manufacturing facility near Bengaluru, which the company says will support its growth journey.
📊 Chemical Intermediates revenue rose 24% YoY to ₹563 crore on steady volumes and improved realisations amid higher input costs from rising crude prices. Specialty Chemicals EBITDA rose 12% YoY to ₹140 crore.
📌 Finance costs rose 85% YoY to ₹23 crore in Q2 FY27.
Also from Jubilant Ingrevia
Jubilant Ingrevia uploads audio recording of Q2/H1 FY27 investors' conference call held October 27, 2026
27 Oct 2026
Jubilant Ingrevia reported revenue growth of 24%, with its chemical segment up 27% and nutrition and health segment up 51%, and net profit surging 61%
27 Oct 2026
Sr. Vice President & Head HR Vinita Koul tenders resignation, effective close of business on November 06, 2026
27 Oct 2026
More numbers
- Total revenue, Q2 FY271,394 (Rs Crore)
- Total EBITDA, Q2 FY27221 (Rs Crore)
- PAT after exceptional items, Q2 FY27111 (Rs Crore)
- Basic and diluted EPS, Q2 FY277.1 (Rs.)
- EBITDA margin, Q2 FY2716%
- Specialty Chemicals revenue560 (Rs Crore)
- Specialty Chemicals EBITDA140 (Rs Crore)
- Nutrition & Health Solutions revenue270 (Rs Crore)
- Nutrition & Health Solutions EBITDA39 (Rs Crore)
- Chemical Intermediates revenue563 (Rs Crore)
- Investment for 40% stake in ZettaOne Technologies₹189.2 crore
- Finance costs, Q2 FY2723 (Rs Crore)
- Stake40%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.